134 related articles for article (PubMed ID: 10714240)
21. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
22. Molecular and metabolic retinoid pathways in the human ocular surface.
Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V
Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666
[TBL] [Abstract][Full Text] [Related]
23. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic applications for ligands of retinoid receptors.
Thacher SM; Vasudevan J; Chandraratna RA
Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
[TBL] [Abstract][Full Text] [Related]
25. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
[TBL] [Abstract][Full Text] [Related]
26. Conformational adaptation of agonists to the human nuclear receptor RAR gamma.
Klaholz BP; Renaud JP; Mitschler A; Zusi C; Chambon P; Gronemeyer H; Moras D
Nat Struct Biol; 1998 Mar; 5(3):199-202. PubMed ID: 9501913
[No Abstract] [Full Text] [Related]
27. Density functional and docking studies of retinoids for cancer treatment.
Silva CH; Almeida P; Taft CA
J Mol Model; 2004 Feb; 10(1):38-43. PubMed ID: 14634847
[TBL] [Abstract][Full Text] [Related]
28. Distinct modes of interaction of the retinoic acid receptor alpha with natural and synthetic retinoids.
Lefebvre B; Mouchon A; Formstecher P; Lefebvre P
Mol Cell Endocrinol; 1998 Apr; 139(1-2):161-9. PubMed ID: 9705084
[TBL] [Abstract][Full Text] [Related]
29. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
Klaholz BP; Mitschler A; Moras D
J Mol Biol; 2000 Sep; 302(1):155-70. PubMed ID: 10964567
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
Yu KL; Spinazze P; Ostrowski J; Currier SJ; Pack EJ; Hammer L; Roalsvig T; Honeyman JA; Tortolani DR; Reczek PR; Mansuri MM; Starrett JE
J Med Chem; 1996 Jun; 39(12):2411-21. PubMed ID: 8691435
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
32. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors.
LeMotte PK; Keidel S; Apfel CM
Biochim Biophys Acta; 1996 Mar; 1289(2):298-304. PubMed ID: 8600988
[TBL] [Abstract][Full Text] [Related]
33. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
Lotan R
Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
[TBL] [Abstract][Full Text] [Related]
34. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models.
Chen S; Ostrowski J; Whiting G; Roalsvig T; Hammer L; Currier SJ; Honeyman J; Kwasniewski B; Yu KL; Sterzycki R
J Invest Dermatol; 1995 May; 104(5):779-83. PubMed ID: 7738355
[TBL] [Abstract][Full Text] [Related]
36. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activation of a model reporter system by retinoids and retinoic acid receptor isoforms.
Huggenvik JI; Sharma RP
Pharmacol Toxicol; 1995 Jan; 76(1):17-22. PubMed ID: 7753751
[TBL] [Abstract][Full Text] [Related]
38. 6'-substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligands.
Graupner G; Malle G; Maignan J; Lang G; Pruniéras M; Pfahl M
Biochem Biophys Res Commun; 1991 Sep; 179(3):1554-61. PubMed ID: 1656958
[TBL] [Abstract][Full Text] [Related]
39. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
40. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
